Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $7.7 million.

  • Select Medical Holdings' Dividends Paid - Common fell 5221.07% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.5 million, marking a year-over-year decrease of 1918.34%. This contributed to the annual value of $64.6 million for FY2024, which is 111.57% up from last year.
  • According to the latest figures from Q3 2025, Select Medical Holdings' Dividends Paid - Common is $7.7 million, which was down 5221.07% from $7.9 million recorded in Q2 2025.
  • Select Medical Holdings' Dividends Paid - Common's 5-year high stood at $22.7 million during Q4 2021, with a 5-year trough of $7.7 million in Q3 2025.
  • In the last 5 years, Select Medical Holdings' Dividends Paid - Common had a median value of $16.0 million in 2023 and averaged $15.1 million.
  • In the last 5 years, Select Medical Holdings' Dividends Paid - Common skyrocketed by 132293.42% in 2021 and then crashed by 5221.07% in 2025.
  • Over the past 5 years, Select Medical Holdings' Dividends Paid - Common (Quarter) stood at $22.7 million in 2021, then fell by 29.92% to $15.9 million in 2022, then crashed by 43.16% to $9.0 million in 2023, then soared by 78.44% to $16.1 million in 2024, then tumbled by 52.0% to $7.7 million in 2025.
  • Its last three reported values are $7.7 million in Q3 2025, $7.9 million for Q2 2025, and $14.7 million during Q1 2025.